These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27170594)

  • 1. High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Regoli F; Bongiorni MG; Rordorf R; Santamaria M; Klersy C; Segreti L; De Regibus V; Moccetti T; Conte G; Caputo ML; Auricchio A
    Eur J Heart Fail; 2016 Oct; 18(10):1270-1277. PubMed ID: 27170594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
    Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: A substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) Registry.
    Regoli F; Auricchio A; Di Cori A; Segreti L; Blomström-Lunqvist C; Butter C; Deharo JC; Kennergren C; Kutarski A; Laroche C; Zalevskiy V; Luzzi G; Cano O; Grabowski M; Rinaldi C; Bongiorni MG
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1086-1095. PubMed ID: 30980441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality after transvenous lead extraction.
    Maytin M; Jones SO; Epstein LM
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):252-7. PubMed ID: 22362891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapy.
    Hayashi K; Younis A; Callahan T; Baranowski B; Martin DO; Nakhla S; Wilkoff BL
    Heart Rhythm; 2023 Jun; 20(6):872-878. PubMed ID: 36933853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.
    Jacheć W; Polewczyk A; Segreti L; Bongiorni MG; Kutarski A
    Gerontology; 2021; 67(1):36-48. PubMed ID: 33242867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?
    Stefańczyk P; Nowosielecka D; Polewczyk A; Tułecki Ł; Tomków K; Jacheć W; Lewicka E; Tomaszewski A; Kutarski A
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
    Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
    J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Same-day discharge after transvenous lead extraction: feasibility and outcomes.
    Atteya G; Alston M; Sweat A; Saleh M; Beldner S; Mitra R; Willner J; John RM; Epstein LM
    Europace; 2023 Feb; 25(2):586-590. PubMed ID: 36575941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
    Seifert M; Moeller V; Arya A; Schau T; Hoelschermann F; Butter C
    Europace; 2018 May; 20(5):808-815. PubMed ID: 28398556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial leads in adult cardiac resynchronization therapy recipients: a study on lead performance, durability, and safety.
    Buiten MS; van der Heijden AC; Klautz RJM; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Mar; 12(3):533-539. PubMed ID: 25460170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.